| Pubmed ID |
Author | Year | Title |
21481088 |
Yilmaz M | 2011 | Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. |
21481376 |
Bellver J | 2011 | Endometrial gene expression in the window of implantation is altered in obese women especially in?association with polycystic ovary syndrome. |
21484319 |
Ghandi S | 2011 | The effects of metformin or orlistat on obese women with polycystic ovary syndrome: a prospective randomized open-label study. |
21485070 |
Li XB | 2011 | [Distribution of Chinese medicine syndrome patterns and its laws in patients with polycystic ovarian syndrome]. |
21485085 |
Wang YR | 2011 | [Effect of sequential method of nourishing yin and tonifying yang on serum sex hormone levels in rats with polycystic ovary syndrome]. |
21486668 |
Berent-Spillson A | 2011 | Insulin resistance influences central opioid activity in polycystic ovary syndrome. |
21487075 |
Raja-Khan N | 2011 | The physiological basis of complementary and alternative medicines for polycystic ovary syndrome. |
21492415 |
Zhang X | 2011 | Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women. |
21495802 |
Wang Q | 2011 | Association between serum adipocyte factor level and insulin resistance in polycystic ovarian syndrome. |
21496806 |
Papaleo E | 2011 | Inositol effects on ovulation induction in patients with polycystic ovary syndrome. |
21496811 |
Rizzo P | 2011 | Comments on the role of inositol supplementation in patients with polycystic ovary syndrome. |
21499461 |
Najem F | 2008 | Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study. |
21500461 |
Dum?chi??-Gargu G | 2010 | [Polycystic ovary syndrome--genetic considerations]. |
21501001 |
Markantes G | 2011 | Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 ?g ethinyl estradiol and 2 mg cyproterone acetate. |
21505042 |
Taylor MC | 2011 | Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome. |
21505333 |
He RH | 2011 | How to deal with fluid in the endometrial cavity during assisted reproductive techniques. |
21508129 |
Schmidt J | 2011 | Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. |
21508897 |
Shivaswamy V | 2011 | Tacrolimus and sirolimus induce reproductive abnormalities in female rats. |
21510080 |
Pinkhasov BB | 2010 | [Nature of obesity and the rate of aging in women with reproductive function disturbances]. |
21510912 |
Tersigni C | 2011 | Adipokines: new emerging roles in fertility and reproduction. |
21511534 |
Fernandez H | 2011 | Ovarian drilling for surgical treatment of polycystic ovarian syndrome: a comprehensive review. |
21511711 |
Pelzer ES | 2011 | Microbial colonization of follicular fluid: alterations in cytokine expression and adverse assisted reproduction technology outcomes. |
21514580 |
Cittadini E | 2011 | The role of inositol supplementation in patients with polycystic ovary syndrome, with insulin resistance, undergoing the low-dose gonadotropin ovulation induction regimen. |
21514585 |
Li Y | 2011 | Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by?abnormally enhanced promoter activity in?polycystic ovary syndrome granulosa cells. |
21514928 |
Elmashad AI | 2011 | Impact of laparoscopic ovarian drilling on anti-M?llerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome. |
21518135 |
Weerakiet S | 2011 | Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome. |
21518564 |
Liao L | 2011 | Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome. |
21521255 |
Joharatnam J | 2011 | Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters. |
21521284 |
Sidhwani S | 2011 | Polycystic ovary syndrome is associated with atherogenic changes in lipoprotein particle number and size independent of body weight. |
21521311 |
Rotondi M | 2011 | Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome. |
21521934 |
Anaforoglu I | 2011 | Relative associations of polycystic ovarian syndrome vs metabolic syndrome with thyroid function, volume, nodularity and autoimmunity. |
21521935 |
Kurdoglu Z | 2012 | Oxidative status and its relation with insulin resistance in young non-obese women with polycystic ovary syndrome. |
21524038 |
Allen G | 2011 | FPIN?s clinical inquiries. Secondary causes of obesity. |
21527854 |
Rashidi B | 2011 | Simvastatin effects on androgens, inflammatory mediators, and endogenous pituitary gonadotropins among patients with PCOS undergoing IVF: results from a prospective, randomized, placebo-controlled clinical trial. |
21528473 |
Lewandowski KC | 2011 | The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS). |
21528474 |
Lenarcik A | 2011 | Hormonal abnormalities in first-degree relatives of women with polycystic ovary syndrome (PCOS). |
21529351 |
Dafopoulos K | 2011 | Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone. |
21530057 |
Hu W | 2011 | Elevated C-reactive protein and monocyte chemoattractant protein-1 in patients with polycystic ovary syndrome. |
21530058 |
De Leo V | 2011 | The administration of metformin during pregnancy reduces polycystic ovary syndrome related gestational complications. |
21530059 |
Graupp M | 2011 | Association of genetic variants in the two isoforms of 5?-reductase, SRD5A1 and SRD5A2, in lean patients with polycystic ovary syndrome. |
21530060 |
Maciel GA | 2011 | Influence of LH and high-density lipoprotein cholesterol (HDL-C) on metformin response in women with polycystic ovary syndrome. |
21535308 |
Bhattacharya SM | 2011 | Prevalence and risk of metabolic syndrome in adolescent Indian girls with polycystic ovary syndrome using the 2009 'joint interim criteria'. |
21536229 |
Yanes LL | 2011 | Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome. |
21536277 |
Billecke SS | 2011 | Pitfalls in the assessment of PON1 status in clinical populations. |
21538144 |
de Oliveira Baraldi C | 2011 | Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome. |
21543377 |
Koiou E | 2011 | Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels. |
21543511 |
Velazquez MA | 2011 | In vivo oocyte developmental competence is reduced in lean but not in obese superovulated dairy cows after intraovarian administration of IGF1. |
21547256 |
Fulghesu AM | 2011 | IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. |
21547513 |
Dilbaz B | 2011 | Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes. |
21549367 |
Lin YH | 2011 | Antim?llerian hormone and polycystic ovary syndrome. |
21549510 |
Jedel E | 2011 | Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome. |
21550041 |
McCormick BA | 2011 | Endometrial thickness predicts endometrial hyperplasia in patients with polycystic ovary syndrome. |
21550088 |
Li HW | 2011 | Vitamin D deficiency is common and associated with metabolic risk factors in patients with polycystic ovary syndrome. |
21550852 |
He D | 2011 | Meta-analysis of letrozole versus clomiphene citrate in polycystic ovary syndrome. |
21552164 |
Tartagni M | 2011 | Pregnancy in a woman with premature ovarian insufficiency undergoing intracytoplasmic sperm injection after pretreatment with estrogens followed by therapy with estrogens associated with ovarian stimulation with gonadotropins: remarks about oocyte and embryo quality. |
21553361 |
Livadas S | 2011 | Menstrual irregularities in PCOS. Does it matter when it starts?. |
21553368 |
Cupisti S | 2011 | The different phenotypes of polycystic ovary syndrome: no advantages for identifying women with aggravated insulin resistance or impaired lipids. |
21556889 |
Reinblatt SL | 2011 | Controversies in IVM. |
21557696 |
Torun AN | 2011 | Paraoxonase-1 is not affected in polycystic ovary syndrome without metabolic syndrome and insulin resistance, but oxidative stress is altered. |
21557697 |
Zhang J | 2011 | The plasma level and gene expression of resistin in polycystic ovary syndrome. |
21557698 |
Pereira M Jr | 2011 | Involvement of GDF-9, leptin, and IGF1 receptors associated with adipose tissue transplantation on fertility restoration in obese anovulatory mice. |
21557918 |
Liu Y | 2011 | Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome. |
21561809 |
Abir R | 2011 | Invited commentary: a single nucleotide polymorphism in BMP15 is associated with high response to controlled ovarian hyperstimulation. |
21562798 |
McGowan MP | 2011 | Polycystic ovary syndrome: a common endocrine disorder and risk factor for vascular disease. |
21562964 |
Kunt C | 2011 | Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization. |
21565677 |
Bentley-Lewis R | 2011 | Ovarian hypertension: polycystic ovary syndrome. |
21569072 |
Gangale MF | 2011 | Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome. |
21573681 |
Bingol B | 2011 | Prenatal diagnosis of Comel-Netherton syndrome with PGD, case report and review article. |
21575217 |
Paredes AH | 2011 | Sympathetic nerve activity in normal and cystic follicles from isolated bovine ovary: local effect of beta-adrenergic stimulation on steroid secretion. |
21575449 |
Ma CS | 2011 | [Preliminary study on the value of ratio of serum luteinizing hormone/follicle-stimulating hormone in diagnosis of polycystic ovarian syndrome among women with polycystic ovary]. |
21575945 |
Chang CY | 2011 | Lower serum apelin levels in women with polycystic ovary syndrome. |
21576081 |
Nahuis MJ | 2011 | Long-term outcomes in women with polycystic ovary syndrome initially randomized to receive laparoscopic electrocautery of the ovaries or ovulation induction with gonadotrophins. |
21577021 |
Koiou E | 2011 | The phenotypes of polycystic ovary syndrome defined by the 1990 diagnostic criteria are associated with higher serum vaspin levels than the phenotypes introduced by the 2003 criteria. |
21584501 |
Kim JH | 2011 | Association study between the -866G/A polymorphism in the promoter of uncoupling protein-2 gene and polycystic ovary syndrome. |
21586896 |
Gambineri A | 2011 | Basal insulin-like factor 3 levels predict functional ovarian hyperandrogenism in the polycystic ovary syndrome. |
21591394 |
Chernukha GE | 2010 | [Drug correction of hormonal disturbances and risk factors of cardiovascular complications in women of reproductive age with polycystic ovary syndrome]. |
21592169 |
Hosseinpanah F | 2011 | The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study. |
21593045 |
Swanton A | 2011 | Do women with ovaries of polycystic morphology without any other features of PCOS benefit from short-term metformin co-treatment during IVF? A double-blind, placebo-controlled, randomized trial. |
21593108 |
Eriksen MB | 2011 | Intact primary mitochondrial function in myotubes established from women with PCOS. |
21594601 |
Abu Hashim H | 2011 | Does laparoscopic ovarian diathermy change clomiphene-resistant PCOS into clomiphene-sensitive? |
21600576 |
Yildizhan R | 2011 | Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome. |
21600812 |
Nidhi R | 2011 | Prevalence of polycystic ovarian syndrome in Indian adolescents. |
21602145 |
Lin Y | 2011 | [Relation between insulin resistance and insulin receptor gene methylation in the endometrium of patients with polycystic ovary syndrome]. |
21602314 |
Wetzka B | 2011 | Anti-Mullerian hormone confirms the novel classification of female functional androgenization including polycystic ovary syndrome. |
21602454 |
Oberfield SE | 2011 | Approach to the girl with early onset of pubic hair. |
21605000 |
L?zaro I | 2011 | Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess. |
21605157 |
Livadas S | 2011 | Anxiety is associated with hormonal and metabolic profile in women with polycystic ovarian syndrome. |
21605417 |
Sabatini ME | 2011 | Metformin therapy in a hyperandrogenic anovulatory mutant murine model with polycystic ovarian syndrome characteristics improves oocyte maturity during superovulation. |
21606131 |
Kj?tr?d SB | 2011 | Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study. |
21606132 |
Legro RS | 2011 | Metformin as adjuvant therapy to IVF in women with PCOS: when is intention-to-treat unintentional? |
21606667 |
Calogero AE | 2011 | Understanding polycystic ovarian syndrome pathogenesis: an updated of its genetic aspects. |
21606690 |
Saha SA | 2011 | Thrombocytosis in patients with polycystic ovary syndrome: reactive or culpable? |
21608442 |
Unfer V | 2011 | Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. |
21609197 |
?lvarez-Blasco F | 2011 | Diet composition and physical activity in overweight and obese premenopausal women with or without polycystic ovary syndrome. |
21611153 |
Jones MR | 2011 | Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome. |
21613813 |
Wehr E | 2011 | Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study. |
21614496 |
Li C | 2011 | Prognostic value of total testosterone for pregnancy during treatment in patients with clomiphene-citrate-resistant polycystic ovary syndrome: a pilot study. |
21615238 |
Ribeiro AL | 2012 | Myeloperoxidases and polycystic ovary syndrome. |
21616917 |
Moran LJ | 2011 | Vascular function in the diagnostic categories of polycystic ovary syndrome. |
21621772 |
Gurgan T | 2011 | Intravenous calcium infusion as a novel preventive therapy of ovarian hyperstimulation syndrome for patients with polycystic ovarian syndrome. |
Showing 9,501–9,600 of 14,368